Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Long-term efficacy of percutaneous thermal ablation for patients with recurrent hepatocellular carcinoma

Nature Clinical Practice Gastroenterology & Hepatology volume 3, pages 250–251 (2006)Cite this article

boxed-textLu MD et al. (2005) Percutaneous thermal ablation for recurrent hepatocellular carcinoma. Br J Surg 92: 1393–1398

Percutaneous thermal ablation is a viable treatment option for select patients with recurrent hepatocellular carcinoma following liver resection

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. El-Serag HG et al. (1999) Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340: 745–750

    Article  CAS  Google Scholar 

  2. Busuttil RW et al. (2005) Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg 241: 905–916

    Article  Google Scholar 

  3. Poon RT et al. (1999) Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 229: 216–222

    Article  CAS  Google Scholar 

  4. Choi D et al. (2004) Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy. Radiology 230: 135–141

  5. Nagasue N et al. (1996) Repeat hepatectomy for recurrent hepatocellular carcinoma. Br J Surg 83: 127–131

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Clinical Instructor in Surgery,

    Michael Zimmerman & Ronald W Busuttil

  2. Professor and Chairman of the Department of Surgery and Chief of the Division of Liver and Pancreas Transplantation at the David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA

    Michael Zimmerman & Ronald W Busuttil

Authors
  1. Michael Zimmerman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ronald W Busuttil
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ronald W Busuttil.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zimmerman, M., Busuttil, R. Long-term efficacy of percutaneous thermal ablation for patients with recurrent hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 3, 250–251 (2006). https://doi.org/10.1038/ncpgasthep0489

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0489

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing